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ID is defined as a diminished total body iron content. Depending on the severity of the deficiency, three degrees of ID are recognized [3] . A negative iron balance leads first to ID with decreased total body iron but unaffected synthesis of hemoglobin (Hb): ID grade I. When the iron supply to the erythropoietic marrow is inadequate, ID grade II occurs, iron-deficient erythropoiesis.
When finally the iron supply is no longer sufficient to maintain a normal concentration of Hb, the most severe phase of ID results, ID anemia (grade III).
Several laboratory tests are used to confirm or exclude ID. In the past, many investigators performed studies to investigate the diagnostic value of the individual tests and to identify the best marker of ID (e.g., [4-13J) .
Some authors found a good correlation between the various markers, but in other studies the correlation was poor. We observed that these discrepancies as well as other problems are mainly caused by failing to take into account the different stages of ID. In our present study we show that simple correlation is not sufficient to investigate the diagnostic value of a laboratory test in ID. ZPP range: 19-3 8 j.Lmollmol heme). When evaluating both groups simultaneously (H + III), however, the same data delivered good correlation (r = -0.77; P <lO"). The best ferritin/ZPP correlation was obtained with the data synopsis from healthy individuals and patients with mild anemia (H + III1).
Materials and Methods

SUBJECTS
All the other tests (saturation of transferrin, hemoglobin, MCV, MCH, sideroblast count) showed the best correlation with ferritin for the data synopsis from healthy individuals and patients with severe anemia (H + III).
Predictive values of the different tests of the iron status as obtained in our study are summarized in Table 3 
"Values are mean ± SD (and range).
Sat,transferrin saturation; SBC, sideroblast count; BM, bone marrow hemosiderin (2 = normal). mia. In our experience, clinical symptoms and anemia usually first appeared when ZPP was >80 moVmol heme. In patients with severe ID anemia (Hb <100 g/L), the ZPP concentrations were always >100 mol/mol heme. In assessing above-normal ZPP values, one must be aware that increased values are measured not only in real ID, but also in all conditions where iron support for erythropoiesis becomes insufficient:
e.g., lead intoxication, anemia of chronic disorders, myelodysplastic syndromes [23] [24] [25] [26] [27] [28] .
In contrast to cases with real ID, ZPP values in myelodysplastic syndromes are even in the most severe cases <80 .tmol/mol heme, usually <60 jtmol/ mol heme [29] . Disturbances of iron metabolism in chronic disorders are usually associated with ZPP <80 .tmolImol heme; ZPP exceeds 100 mol/mol heme only in severe cases [25] . Clinically relevant lead intoxication, on the other hand, is associated with very high ZPP, always >1000 jimol/mol heme in our patients.
Transferrin saturation is considered the best marker of the iron supply for erythropoiesis [4] . In clinical practice, however, the saturation obtained supports a definite statement only if the value is very low or very high [9] . Values 15% are regarded as proof of deficient iron delivery to erythropoiesis [4] . Therefore, transferrin saturation is a marker of iron-deficient erythropoiesis.
Hb concentrations <130 g/L in men and <120 g/L in women define the last stage of iron deficiency, ID anemia. Given that many conditions lead to low Hb concentrations, ID anemia cannot be diagnosed by a low Hb only.
The red cell indices MCV and MCH are predictive of only late ID anemia [3, 5, [8] [9] [10] . Statements such as "MCV detects iron deficiency in 50%" are misleading, because these markers work only in severe ID anemia and show no conclusive changes in the first two stages of ID. Thus, the "sensitivity" of MCV obtained without ID staging depends primarily on the composition of the groups of patients examined.
This by inflammatory diseases). We also prefer this strategy in hematologic patients, particularly in those with anemia. Simultaneous determination of ferritin and ZPP is of practical interest in hemochromatosis patients treated by venesection as well, to guarantee iron depletion and prevent the development of iron-deficient erythropoiesis in such patients [19] .
In our daily clinical routine, however, we use only ZPP as the first-line test and determine ferritin in a second step, if necessary, to distinguish between real ID and sideroachrestic disorders (Fig. 1) . Although this strategy does not detect cases with iron depletion, we find it justifiable because, except for heniochromatosis, whether the iron stores are full or only half full is of little clinical relevance, and, except for a neoplasia (where ferritin values frequently do not work well), early detection of decreased body iron stores is not of vital interest. In clinical practice, physicians want to know whether or not a given patient has clinically relevant ID and whether the symptoms or pathological findings (e.g., anemia) are caused by ID. ZPP always detects an iron-deficient erythropoiesis, the first clinically relevant stage of ID [19] .Normal or only slightly increased ZPP values exclude clinically relevant ID and show the physician that, whatever the pathological findings for the given patient, they are not caused by ID (Fig. 1) [36] [37] [38] [39] [40] .
The lack of correlation between ferritin and other markers is generally interpreted off-hand as a defect of the latter and that marker is rejected as a valid test of ID. Our results should warn against such uncritical acceptance of statistics and against the use of statistics without careful analysis of the underlying assumptions. The data from patients with severe ID anemia, for example, show no correlation between ferritin and ZPP concentrations, although both markers deliver "correct" results and allow for correct diagnosis in all cases. The reason for this is trivial (Fig.  2) : Ferritin, as a marker of the iron stores, shows the same low As shown, ferritin and ZPP (and other tests that relate to iron utilization for erythropoiesis) are completely independent markers. In the case of a negative iron balance, ferritin falls continually, whereas ZPP is not affected until the iron support to erythropoiesis becomes insufficient. values in all patients (range: 2 -10 g/L), because the iron stores are exhausted; ZPP, in contrast, varies according to the severity of the iron-deficient erythropoiesis (range 12 7-556 .tmol/mol heme). Thus, in severe ID anemia, ZPP is superior to ferritin, diagnosing not only the ID but also the severity of the irondeficient erythropoiesis.
The lack of correlation observed is not the result of ZPP insensitivity, but rather the fact that the ferritin values can show no further decline in advanced ID (Fig.  2) . Healthy individuals also showed poor ferritin/ZPP correlation, even though the individual ferritin and ZPP values were all correctly within the normal range. In these patients ZPP showed minimal variation that was not dependent on the storage marker ferritin, which varied according to the amount of the storage iron.
The (Fig. 2) . This mathematical trick, in which only the endpoint data are used, always produces good correlation between two variables and accounts for the good correlations observed between ferritin and the other tests in our study.
Of course, poor correlation between the measured values of two different markers of ID does not necessarily mean a lack of diagnostic correlation.
In patients with severe ID anemia (IllS), for example, the ferritin and ZPP values do not correlate; nonetheless, the low ferritin values allow the correct diagnosis of ID just as well as the high ZPP values do. Thus, despite poor correlation between the measured values, the diagnoses themselves correlate well. The diagnosis of ID as currently practiced is mainly based on data from epidemiological studies without consideration of the severity of ID. Under these conditions, however, knowledge of the "ID sensitivity" of various laboratory tests is useless for individual cases. Studies of iron metabolism should not have the goal of determining the "best" marker, for none exists: ID is a dynamic process and cannot be defined by one test only. To understand the clinical severity of ID in a given patient, one must know which stage of ID the individual test detects and by which factors it is disturbed.
By detecting different stages, the various markers efficiently complement each other to characterize ID severity in an individual case (Fig. 3 ).
In conclusion, the iron status of a given patient can be assessed according to the following schema: Low ferritin indicates exhausted iron stores. ZPP determinations show whether or not the diagnosed ID in such a case is of clinical relevance. The extent of the clinically relevant ID can finally be assessed by the measured value of ZPP, the Hb concentration, and the red cell indices.
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